Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384

Defining the clinical course of multiple sclerosis

LUBLIN, F. D., & Reingold, S. C. (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,762

Generalized Linear Models

Schuenemeyer, J. H., McCullagh, P. J., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,702

Interferon beta‐lb in the treatment of multiple sclerosis

The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995) · Neurology · doi:10.1212/wnl.45.7.1277 · Cited by 971

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

Miller, D. (1998) · Brain · doi:10.1093/brain/121.1.3 · Cited by 553

Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology

Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 520

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

O’Riordan, J. I. (1998) · Brain · doi:10.1093/brain/121.3.495 · Cited by 480

Accumulation of hypointense lesions ("black holes") on T 1 spin-echo MRI correlates with disease progression in multiple sclerosis

Truyen, L., van Waesberghe, J. H. T. M., van Walderveen, M. A. A., van Oosten, B. W., Polman, C. H., Hommes, O. R., Adèr, H. J., & Barkhof, F. (1996) · Neurology · doi:10.1212/wnl.47.6.1469 · Cited by 461

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340507 · Cited by 387

Does one guideline fit all?

Richert, N. D., & Kryscio, R. J. (2011) · Neurology · doi:10.1212/wnl.0b013e31823d76ba · Cited by 2

Therapy in clinical practice

Cohen, J. A., & Rudick, R. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.054 · Cited by 3

Basic mechanisms

Kesselring, J., Comı, G., & Thompson, A. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781698.002 · Cited by 2

Reply

Rovaris, M., Comı, G., Sormani, M. P., Wolinsky, J. S., Ladkani, D., & Filippi, M. (2001) · Annals of Neurology · doi:10.1002/ana.1148 · Cited by 2

Advances in Multiple Sclerosis Imaging

Pirko, I. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00005-x · Cited by 1

Supervised automatic procedure to identify new lesions in brain MR longitudinal studies of patients with multiple sclerosis

Parodi, R. C., Levrero, F., Sormani, M. P., Pilot, A., Mancardi, G., Aliprandi, A., & Sardanelli, F. (2008) · La radiologia medica · doi:10.1007/s11547-008-0251-z · Cited by 1

Die Wertigkeit der evozierten Potenziale in der Diagnostik der multiplen Sklerose

Haarmeier, T., & DICHGANS, J. (2005) · Springer eBooks · doi:10.1007/3-540-26659-3_5 · Cited by 1

MAGNETIC RESONANCE IMAGING OF MULTIPLE SCLEROSIS

Naismith, R. T., & Cross, A. H. (2007) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293643.43858.9a · Cited by 1

MULTIPLE SCLEROSIS CLINICAL TRIAL DESIGN AND ANALYSIS

Burton, J., & O'Connor, P. W. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293632.77732.a8 · Cited by 1

Examination of the Role of MRI in Multiple Sclerosis: A Problem Orientated Approach

McFarland, H. F. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_33 · Cited by 1

Recomendaciones para la coordinación de los servicios de Neurología y Neurorradiología en la atención a pacientes con esclerosis múltiple

Llufriú, S., Agüera, E., Costa‐Frossard, L., Galán, V., Landete, L., Lourido, D., Meca-Lallana, J. E., Moral, E., Bravo-Rodríguez, F. A., Koren, L., et al. (2021) · Neurología · doi:10.1016/j.nrl.2021.01.012 · Cited by 1

▼Glatiramer acetate for multiple sclerosis

(2001) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2001.39641 · Cited by 1

Multiple Sclerosis

Narayan, R., Stüve, O., & Shah, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00046-1 · Cited by 3

Measuring disability progression in multiple sclerosis

Achiron, A. (2006) · Journal of Neurology · doi:10.1007/s00415-006-6006-7 · Cited by 1

Surrogate Markers in Multiple Sclerosis

Rocca, M. A., Comı, G., & Filippi, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00015-5 · Cited by 2

Structural and Functional Neuroimaging in Multiple Sclerosis: From Atrophy, Lesions to Global Network Disruption

Tewarie, P. K. B., Schoonheim, M. M., & Hillebrand, A. (2018) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-78926-2_8 · Cited by 1

Where there is inflammation, treatment may reduce disability progression – Commentary

Rube, J., & Lisak, R. P. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518799639 · Cited by 1

Esclerosis múltiple altamente activa y su influencia en la elección del tratamiento

Barboza, A. G., Burgos, M., Cáceres, F., Carrá, A., Correale, J. D., Cristiano, E., Patrucco, L., Piedrabuena, R., Rojas, J. I., Sinay, V. J., et al. (2021) · Neurología Argentina · doi:10.1016/j.neuarg.2021.10.002 · Cited by 1

Intérêt du recalage automatique des IRM cérébrales dans le suivi des scléroses en plaques

Lebrun‐Frénay, C., Rey, D., Chanalet, S., Bourg, V., Bensa, C., Chatel, M., Ayache, N., & Malandain, G. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71034-6 · Cited by 1

How different MR imaging criteria relate to the diagnosis of multiple sclerosis and its outcome

Kido, D. K., Tong, K. A., & Giang, D. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00031-5 · Cited by 1

Long-term interferon in MS: safe, but what effect on disability?

Scolding, N. J. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208017 · Cited by 1

Neuroradiologia e sclerosi multipla

Gallo, A., & Tedeschi, G. (2011) · Springer eBooks · doi:10.1007/978-88-470-1711-5_2

Treatment of Axial Mobility Deficits in Movement Disorders

Bloem, B. R., Orhan, E. K., & de Leeuw, F. (2005) · Neurological disease and therapy · Cited by 1

Therapie der Multiplen Sklerose: Wer? Was? Wann? Wie lange?

Vass, K., & Schmied, M. (2001) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1

Treatment of Axial Mobility Deficits in Movement Disorders

Bloem, B. R., de Leeuw, F., & Orhan, E. K. (2005) · Neurological disease and therapy · doi:10.1201/b14109-16 · Cited by 1

Functional MRI

Filippi, M., & Rocca, M. A. (2003) · Springer eBooks · doi:10.1007/978-88-470-2237-9_7 · Cited by 1

Multiple Sclerosis

Bergers, E., & Barkhof, F. (2001) · Medical radiology · doi:10.1007/978-3-642-56662-2_16 · Cited by 1

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients

Lebrun, C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.119

The use of MRI in multiple sclerosis clinical trials

Bermel, R. A., Fisher, E., Imrey, P. B., & Cohen, J. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.019

Magnetresonanztomografie

Sailer, M. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22083-8.00012-2

Clinical and Neuroimaging Assessments for Research Studies (Including Drug Trials) in Multiple Sclerosis

Apperson, M., & Agius, M. A. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns1004s54

Imaging patterns of inflammation in multiple sclerosis: a multifocal approach

Vellinga, M. M. (2009) · Pure Amsterdam UMC

Chapter 9 Magnetic Resonance Imaging Monitoring in Clinical Trials

Miller, D. H. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70038-8

Multipl Skleroz TanısındaMagnetik Rezonans Görüntülemenin Yeri

Karagöz, E. (2001) · Turkiye Klinikleri Tip Bilimleri Dergisi

Immunologische Effekte von Interferon beta und Glatiramerazetat in der Behandlung der Multiplen Sklerose

Berger, T., & Ehling, R. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH)

Afferent Visual Pathway Assessment in an Exploratory Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis

Kolappan, M. (2013) · UCL Discovery (University College London)

Design for the Next Trials of Neurodegeneration

Sørensen, P. S. (2008) · Springer eBooks · doi:10.1007/978-88-470-0391-0_17

Predicting the On-Study Relapse Rate for Multiple Sclerosis Patients in Clinical Trials

Held, U., Heigenhauser, L., Shang, C., Kappos, L., & Polman, C. H. (2005) · Econstor (Econstor) · doi:10.5282/ubm/epub.1799

Objektivierbarkeit und prognostische Faktoren des Krankheitsverlaufes der Multiplen Sklerose

Gold, R., & Weilbach, F. X. (2001) · Springer eBooks · doi:10.1007/978-3-642-59453-3_8

Diagnosis of Multiple Sclerosis in a Previously Asymptomatic Woman After Ruptured Ectopic Pregnancy and Cardiac Arrest

Veerappan, V., & DiCamillo, A. (2014) · Journal of Neurology Research · doi:10.14740/jnr.v4i4.286

Neue MRT-Techniken zur Bewertung des Therapieeffekts in Studien und in der Praxis?

Fazekas, F., Ropele, S., Enzinger, C., Khalil, M., Wallner-Blazek, M., Seifert‐Held, T., Storch, M. M. L., Archelos, J. J., & Fuchs, S. C. P. C. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)

Heterogeneity in multiple sclerosis; a bio-marker approach

Zwemmer, J. (2011) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)

Magnetic Resonance Imaging Predictors for Disability in Multiple Sclerosis

Minneboo, A. (2008) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)

Papel de la resonancia magnética en el diagnóstico y evaluación del tratamiento de los pacientes con esclerosis múltiple

Velasco, P. E. B. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70065-8

Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: a Phase I/II Study with Riluzole

Kalkers, N. F., Barkhof, F., Bergers, L. L., van Schijndel, R. A., & Polman, C. H. (2004) · Springer eBooks · doi:10.1007/978-88-470-2117-4_4

Prospective, Longitudinal, Multicenter Observational Study of Long-term Treatment with Intramuscular Interferon β-1a of Patients with Clinically Isolated Syndrome at High Risk of Conversion

Guillermo, H. P. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000193

Brain–specific proteins in Multiple Sclerosis

Petzold, A. (2003) · UCL Discovery (University College London)

From immunology to MRI data anlysis : problems in mathematical biology

Waters, R. S. (2015)

Neuroprotective autoimmunity: Reappraising current therapeutic approach and future perspectives

del Barco, D. G., Pentón, E., Montero, E., & Berlanga, J. (2007) · Biotecnología aplicada

Advances in Magnetic Resonance Imaging of Multiple Sclerosis

Zivadinov, R. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-860-7_6

Gadolinium-Enhanced MRI Lesions: What Is Their Prognostic Value in MS?

Khoury, S. J. (1999) · Journal watch · doi:10.1056/jn199908010000012

Zerebrale und spinale MRT-Untersuchung bei Patienten mit klinisch isoliertem Syndrom oder gesicherter Multipler Sklerose Cerebral and Spinal MRI Examination in Patients with Clinically Isolated Syndrome and Definite Multiple Sclerosis

Sailer, M., Fazekas, F., Kappos, L., Rieckmann, P., Toyka, K. V., Wiendl, H., & Bendszus, M. (2008)

Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis

Stone, L. A., Cutter, G., Fisher, E., Richert, N. D., McCartin, J., Ohayon, J. M., Bash, C. N., & McFarland, H. F. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12321

Intramuscular Interferon Beta-1a and Evolving Treatment Options and Outcomes Measurement for MS: Considerations for Managed Care

Barnes, C. J., Caon, C., Foley, J. F., Friedman, M., Menzin, J., Nair, K. V., Nichols, C. I., Olvey, E. L., Owens, G. M., Pill, M. W., et al. (2013) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2013.19.s1.1

Magnetisation transfer imaging in the study of early relapsing-remitting multiple sclerosis

Davies, G. R. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)

OCT in Relapsing–Remitting Multiple Sclerosis (RRMS)

Saidha, S., & Calabresi, P. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20970-8_8

in Multiple s clerosis: An Imaging Marker of Disease 1

Walsh, A. J. L., Blevins, G., Lebel, R. M., Seres, P., Emery, D. J., & Wilman, A. H. (2014)

Optical coherence tomography and brain magnetic resonance imaging in multiple sclerosis

Saidha, S., & Calabresi, P. A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649506.011

Slowing the Progression of Multiple Sclerosis

Rudick, R. A. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50005-9

The multiple sclerosis disease process as characterized by magnetic resonance imaging

Wolinsky, J. S. (2007) · CRC Press eBooks · doi:10.3109/9780203012055-5

A histopathological and magnetic resonance imaging assessment of myelocortical multiple sclerosis: A new pathological variant

Vignos, M. (2016) · OhioLink ETD Center (Ohio Library and Information Network)

Multipl Sklerozisin İmmünpatogenezi Kısım 2: Hastalığın doğușu ve yükseliși

Atay, V., & Kurne, T. (2016) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.1501/tipfak_0000000923

Serial Magnetic Resonance Imaging in Patients with a First Clinical Episode Suggestive of Multiple Sclerosis: Outline of a Research Protocol

Pozzilli, C., Pantano, P., Legge, S. D., Caramia, F., Piattella, M. C., Pestalozza, I. F., Nucciarelli, W., Paolillo, A., Bozzao, L., & Lenzi, G. L. (2004) · Springer eBooks · doi:10.1007/978-88-470-2117-4_13

Multiple Sclerosis

Ahmad, M. I. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47904-2.00046-5

Ablagerung von gadoliniumhaltigen Kontrastmitteln im Gehirn nach mehrfacher Anwendung: Konsequenzen für den Einsatz der MRT bei Diagnosestellung und Verlaufsbeurteilung der Multiplen Sklerose? Accumulation of Gadolinium-based Contrast Agents in the Brain Due to Repetitive Contrast-enhanced MRI: Implications for the Use of MRI in the Diagnosis and Follow-up of Multiple Sclerosis Patients?

Fiehler, J., Siemonsen, S., Zipp, F., Hemmer, B., & Mühlau, M. (2016)

Use of Imaging in Multiple Sclerosis

Filippi, M., Rocca, M. A., Arnold, D. L., Bakshi, R., Barkhof, F., Stefano, N. D., Fazekas, F., Frohman, E. M., & Wolinsky, J. S. (2006) · Wiley eBooks · doi:10.1002/9780470753279.ch6

Case Examples of Using Quantitative Pharmacology in Developing Therapeutic Proteins in Multiple Sclerosis – Peginterferon Beta‐1a, Daclizumab Beta, Natalizumab

Hu, X. S., Hang, Y., Diao, L., Muralidharan, K. K., & Nestorov, I. A. (2019) · Wiley eBooks · doi:10.1002/9781119289234.ch18

MR finds widespread clinical use in MS diagnosis, management

Hutton, G. J., Miller, J. R., & Radue, E. W. (2005)

Neuroimaging in Multiple Sclerosis

Tedeschi, G., Docimo, R., Bisecco, A., & Gallo, A. (2013) · Springer eBooks · doi:10.1007/978-88-470-2676-6_8

Negative prognostic factors in multiple sclerosis

Piťha, J. (2021) · Neurologie pro praxi · doi:10.36290/neu.2020.098

Literatur

(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22085-2.00028-8

Multiple Sclerosis

Kálmán, B. (2007) · Wiley eBooks · doi:10.1002/9780470692363.ch3

References

(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7

Faculty Opinions recommendation of Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.

Cavaletti, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735057914.793557866

Magnetresonanztomografie

Sailer, M., Köhler, W., & Hoffmann, F. A. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22084-5.00012-3

Faculty Opinions recommendation of Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.

Milano, F. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737150193.793569284

Behavioral and imaging markers of multiple sclerosis

Kincses, B. (2020) · doi:10.14232/phd.10607

MRI in MS

(2003) · CRC Press eBooks · doi:10.1201/b14727-7

Multiple Sklerose

Jung, P., & Ziemann, U. (2007) · Springer eBooks · doi:10.1007/978-3-540-71905-2_22

Prediction of response to disease-modifying therapy in multiple sclerosis

Abdalla, A. M., Nasser, A. A., Fouad, M., & Swelam, M. S. (2023) · Journal of Medicine in Scientific Research · doi:10.59299/2537-0928.1044

Estudo da atividade de células citotóxicas em portadores de esclerose múltipla em uso de diferentes tratamentos

Boldrini, V. D. O. (2020) · doi:10.47749/t/unicamp.2020.1238365

Ultrashort Echo Time Magnetic Resonance Imaging of Myelin in Multiple Sclerosis

Du, J., Ma, Y., Zeng, C., Sedaghat, S., Jang, H., & Bydder, G. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-35197-6_40

Magnetic resonance imaging of the multiple sclerosis lesions

Calabrese, M., & Tamanti, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00012-5

Spinal cord imaging in multiple sclerosis

Lorefice, L., & Fenu, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00006-x

Evaluation of Disease Modifying Therapies and Prognostic Factors Affecting Multiple Sclerosis Progression in a Local Centre of Hong Kong

Lui, B. C. M., Li, J. T. C., Lo, W. T., & Fong, W. C. (2025) · Pragmatic and Observational Research · doi:10.2147/por.s556886

Immunotherapeutic Strategies for Multiple Sclerosis

Hohlfeld, R. (2001) · Springer eBooks · doi:10.1007/978-3-662-04450-6_4

Use of MRI in the clinical management of multiple sclerosis

Phillips, J. T., & Stone, L. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.058

Multiple Sclerosis and Acute Disseminated Encephalomyelitis: Evidence-Based Neuroimaging

Zapadka, M. E., & Johnson, A. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3320-0_10

Multiple sclerosis relapse risk factors across treatment eras

Madill, E. S., Healy, B. C., Polgar‐Turcsanyi, M., & Chitnis, T. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251408619

Détection et suivi longitudinal des anomalies de la substance blanche et de la substance grise dans la sclérose en plaques par des approches régionales et statistiques d’IRM de tenseur de diffusion

Hannoun, S. (2011) · theses.fr (ABES) · doi:10.70675/222a569eze215z4c96zaf5bz7b6bfcd85f96

Biological mechanisms driving neurodegeneration in Multiple Sclerosis : an in vivo approach combining positron emission tomography and high field magnetic resonance imaging

Poirion, É. (2019) · theses.fr (ABES) · doi:10.70675/af74bee9zf8f6z4268z9d3cz49018dd637f7

Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors

Bonnan, M., Kit Yi, W. U., Wahab, A., Zedet, M., GRIMALDOS, A., Lafont, C., & Créange, A. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107318

Patient reported outcomes capture subtle changes in disease

Middleton, R. M., Craig, E. M., Rodgers, W., & Nicholas, R. (2026) · BMJ · doi:10.1136/bmj-2026-100021

Management of Multiple Sclerosis: Incorporating Recent Advances in Pathophysiology and Diagnosis to Guide Treatment Strategies

Amin, M., Palmer, K. N., Samara, A., & Cohen, J. A. (2026) · Drugs · doi:10.1007/s40265-026-02391-1

Walking and strength outcomes of targeted hip resistance training may be predicted by both MRI and clinical measures in multiple sclerosis

Fritz, N. E., Eloyan, A., Keller, J. L., & Zackowski, K. M. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107970

The investigation of early MRI in diagnosis and prognosis in patients presenting with a clinically isolated syndrome characteristic of demyelination

Swanton, J. K. (2009) · UCL Discovery (University College London)

Korelacja obrazu MRI z neuropatologią i kliniką w stwardnieniu rozsianym

Gierach, P., & Glabinski, A. R. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)

Measurement of Blood-Brain Barrier Permeability in Multiple Sclerosis

Soon, D. T. L., & Miller, D. H. (2004) · Springer eBooks · doi:10.1007/978-88-470-2127-3_2

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

Koudriavtseva, T., Thompson, A. J., Fiorelli, M., Gasperini, C., Bastianello, S., Bozzao, A., Paolillo, A., Pisani, A., Galgani, S., & Pozzilli, C. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.285 · Cited by 95

The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis-preliminary results

Losseff, N. A., Miller, D. H., Kidd, D. P., & Thompson, A. J. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700105 · Cited by 31

Clinical and Magnetic Resonance Imaging Predictors of Disability in Primary and Secondary Progressive Multiple Sclerosis

Losseff, N. A., Kingsley, D. P. E., McDonald, W. I., Miller, D., & Thompson, A. J. (1996) · Multiple Sclerosis Journal · doi:10.1177/135245859600100406 · Cited by 73

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis

Tortorella, C., Bellacosa, A., Paolicelli, D., Fuiani, A., Monte, E. D., Simone, I. L., Giaquinto, P., Livrea, P., & Trojano, M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.006 · Cited by 70

Resonancia magnética con gadolinio en la fase aguda de las recaídas en esclerosis múltiple

Salas, P. A. O., Silva, J. B., Lopez, L. C., Vergara, K. R., & Rovira, À. (2017) · Revista de Neurología · doi:10.33588/rn.6406.2016310 · Cited by 4